Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've missed a Mounjaro injection, the honest answer is that one skipped dose is unlikely to derail your progress — but how you handle it depends on how much time has passed. Mounjaro (tirzepatide) is a once-weekly prescription medicine, and its dosing schedule is designed with some flexibility built in. That said, these are prescription-only medicines and any questions about your specific situation belong with your prescriber. This page explains the key facts so you can act with confidence rather than anxiety.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people assume that a single missed injection wipes out their progress or forces them back to 2.5mg. That's not the case. Mounjaro (tirzepatide) has a relatively long half-life (around five days) which means meaningful concentrations of the medicine remain in your system for several days after a missed weekly dose. One missed injection is not a reset.
The practical consequence of this is that if you realise you've forgotten your injection and it's been fewer than four days since your scheduled day, the standard guidance is to take the missed dose as soon as you remember. You'd then resume your usual weekly schedule from that new date. Missing a full week changes the calculation, and it's worth reading the detail on that carefully.
If you feel uncertain, the Patient Information Leaflet supplied with your pen covers this clearly, and the NHS medicines page for tirzepatide provides plain-English guidance on what to do. Your prescriber at nume is also available through aftercare seven days a week if you're unsure which situation applies to you.
If five or more days have passed since your missed dose, the guidance shifts. In that situation you'd generally skip the missed injection entirely and return to your scheduled day the following week rather than doubling up. Taking two doses close together raises the risk of more pronounced side effects without providing meaningful additional benefit.
Where it gets more nuanced is after a gap of two weeks or more. Missing two consecutive weeks may mean your prescriber recommends restarting at a lower dose to let your system readjust, particularly if you'd recently moved up in dose. The gastrointestinal effects that typically ease during titration (nausea, stomach discomfort) can feel more noticeable again after a longer break. That's not dangerous, but it is something to manage carefully. Our clinical team reviews exactly these scenarios in aftercare consultations.
The principle behind all of this is the same: avoid the instinct to overcorrect. Taking extra medicine to compensate for a missed dose does not accelerate weight loss and increases the likelihood of side effects. How many days you can safely miss before it affects your treatment is covered in more detail in our dedicated guide.
One thing people don't always anticipate is that returning to Mounjaro after a break of a week or more can feel like a partial restart. Tirzepatide slows gastric emptying and suppresses appetite through dual GIP and GLP-1 receptor activity, and when those effects ease off during a gap, the digestive system partly returns to its previous baseline. Reintroducing the medicine can bring nausea or loose stools back, even at a dose that previously felt settled.
This is temporary and typically settles within a few days, just as it did when you first started or increased your dose. Staying hydrated, eating smaller portions and avoiding high-fat meals around injection day are practical steps that make restarting more comfortable. The Mounjaro SmPC on the electronic Medicines Compendium has the full clinical detail if you want to read the prescribing information directly.
If side effects feel more severe than expected after restarting, or you experience strong, persistent stomach pain that spreads toward your back, seek medical attention promptly. That symptom pattern warrants a same-day clinical assessment. You can also report unexpected reactions via the MHRA's Yellow Card scheme.
An honest acknowledgement here: if you're reading this page, there's a reasonable chance you've been struggling to stay consistent, whether that's because of travel, a busy period, or simply forgetting. That's more common than people realise, and it doesn't mean the treatment isn't working for you.
What it does mean is that a conversation with your prescriber is worth having. Irregular dosing makes it harder to assess whether a dose increase is appropriate or how the treatment is actually performing. It can also complicate the titration schedule. If you're wondering whether occasional missed weeks matter in the long run, the answer depends on frequency and context, and that's exactly the kind of question that deserves a real clinical answer rather than a general one.
For a broader understanding of how tirzepatide works and what the full treatment journey looks like, the tirzepatide overview covers the mechanism, the clinical evidence from SURMOUNT-1 and the licensed indications in detail. If cost or commitment is part of what's making consistency harder, the Mounjaro cost page explains what's included in private treatment pricing. When you're ready to speak to a prescriber directly, starting a free consultation is the right next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.